|
1
|
Matthews NH, Li WQ, Qureshi AA, Weinstock
MA and Cho E: Epidemiology of Melanoma. In: Cutaneous Melanoma:
Etiology and Therapy [Internet]. Ward WH and Farma JM (eds). Codon
Publications, Brisbane (AU), Dec 21, 2017.
|
|
2
|
Paulson KG, Gupta D, Kim TS, Veatch JR,
Byrd DR, Bhatia S, Wojcik K, Chapuis AG, Thompson JA, Madeleine MM
and Gardner JM: Age-specific incidence of melanoma in the United
States. JAMA Dermatol. 156:57–64. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Eggen CAM, Durgaram VV, van Doorn R, Mooi
WJ, Pardo LM, Pasmans SGMA and Hollestein LM: Incidence and
relative survival of melanoma in children and adolescents in the
Netherlands, 1989-2013. J Eur Acad Dermatol Venereol. 32:956–961.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Whiteman DC, Valery P, McWhirter W and
Green AC: Risk factors for childhood melanoma in Queensland,
Australia. Int J cancer. 70:26–31. 1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dean PH, Bucevska M, Strahlendorf C and
Verchere C: Pediatric melanoma: A 35-year population-based review.
Plast Reconstr Surg Glob Open. 5(e1252)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Strouse JJ, Fears TR, Tucker MA and Wayne
AS: Pediatric melanoma: Risk factor and survival analysis of the
Surveillance, Epidemiology and End Results database. J Clin Oncol.
23:4735–4741. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Farello G, Altieri C, Cutini M, Pozzobon G
and Verrotti A: Review of the literature on current changes in the
timing of pubertal development and the incomplete forms of early
puberty. Front Pediatr. 7(147)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Berg P and Lindelof B: Differences in
malignant melanoma between children and adolescents. A 35-year
epidemiological study. Arch Dermatol. 133:295–297. 1997.PubMed/NCBI
|
|
9
|
Folkerd EJ and Dowsett M: Influence of sex
hormones on cancer progression. J Clin Oncol. 28:4038–4044.
2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dika E, Patrizi A, Lambertini M,
Manuelpillai N, Fiorentino M, Altimari A, Ferracin M, Lauriola M,
Fabbri E, Campione E, et al: Estrogen receptors and melanoma: A
review. Cells. 8(1463)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Marzagalli M, Marelli MM, Casati L,
Fontana F, Moretti RM and Limonta P: Estrogen receptor β in
melanoma: From molecular insights to potential clinical utility.
Front Endocrinol (Lausanne). 7(40)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Schmidt AN, Nanney LB, Boyd AS, King LE
and Ellis DL: Oestrogen receptor-beta expression in melanocytic
lesions. Exp Dermatol. 15:971–980. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
de Giorgi V, Gori A, Gandini S, Papi F,
Grazzini M, Rossari S, Simoni A, Maio V and Massi D: Oestrogen
receptor beta and melanoma: A comparative study. Br J Dermatol.
168:513–519. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Donley GM, Liu WT, Pfeiffer RM, McDonald
EC, Peters KO, Tucker MA and Cahoon EK: Reproductive factors,
exogenous hormone use and incidence of melanoma among women in the
United States. Br J Cancer. 120:754–760. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kvaskoff M, Bijon A, Mesrine S,
Boutron-Ruault MC and Clavel-Chapelon F: Cutaneous melanoma and
endogenous hormonal factors: A large French prospective study. Am J
Epidemiol. 173:1192–1202. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Holly EA, Cress RD and Ahn DK: Cutaneous
melanoma in women: Ovulatory life, menopause, and use of exogenous
estrogens. Cancer Epidemiol Biomarkers Prev. 3:661–668.
1994.PubMed/NCBI
|
|
17
|
MacKie RM and Bray CA: Hormone replacement
therapy after surgery for stage 1 or 2 cutaneous melanoma. Br J
Cancer. 90:770–772. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Caini S, Radice D, Tosti G, Spadola G,
Cocorocchio E, Ferrucci PF, Testori A, Pennacchioli E, Fargnoli MC,
Palli D, et al: Risk of second primary malignancies among 1537
melanoma patients and risk of second primary melanoma among 52 354
cancer patients in Northern Italy. J Eur Acad Dermatol Venereol.
30:1491–1496. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Goggins W, Gao W and Tsao H: Association
between female breast cancer and cutaneous melanoma. Int J Cancer.
111:792–794. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Secreto G, Girombelli A and Krogh V:
Androgen excess in breast cancer development: Implications for
prevention and treatment. Endocr Relat Cancer. 26:R81–R94.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Min M, Ghosh S, Tavernari D, Katarkar A,
Clocchiatti A, Mazzeo L, Samarkina A, Epiney J, Yu YR, Ho PC, et
al: Sustained androgen receptor signaling is a determinant of
melanoma cell growth potential and tumorigenesis. J Exp Med.
8(e20201137)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Goldenberg A, Jiang SI and Cohen PR: A
possible association between melanoma and prostate cancer. Results
from a case-control-study. Cancers (Basel). 7:670–678.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rampen FH and Mulder JH: Malignant
melanoma: An androgen-dependent tumour? Lancet. 1:562–564.
1980.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Slominski A, Tbin DJ, Shibahara S and
Wortsman J: Melanin pigmentation in mammalian skin and its hormonal
regulation. Physiol Rev. 84:1155–1228. 2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bonilla C, Lewis SJ, Martin RM, Donovan
JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama
AA, et al: Pubertal development and prostate cancer risk: Mendelian
randomization study in a population-based cohort. BMC Med.
14(66)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Allil PA, Visconti MA, Castrucci AM and
Isoldi MC: Photoperiod and testosterone modulate growth and
melanogenesis of S91 murine melanoma. Med Chem. 4:100–105.
2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim SH, Richardson M, Chinnakannu K, Bai
VU, Menon M, Barrack ER and Reddy GP: Androgen receptor interacts
with telomeric proteins in prostate cancer cells. J Biol Chem.
285:10472–10476. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhou J, Richardson M, Reddy V, Menon M,
Barrack ER, Reddy GP and Kim SH: Structural and functional
association of androgen receptor with telomeres in prostate cancer
cells. Aging. 5:3–17. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nan H, Du M, De Vivo I, Manson JE, Liu S,
McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, et al: Shorter
telomeres associate with a reduced risk of melanoma development.
Cancer Res. 71:6758–6763. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hsueh EC, Gupta RK, Lefor A, Reyzin G, Ye
W and Morton DL: Androgen blockade enhances response to melanoma
vaccine. J Surg Res. 110:393–398. 2003.PubMed/NCBI View Article : Google Scholar
|
